Solstice Biologics has named Lou Tartaglia as its president and CEO, as well as a member of its board of directors.
Tartaglia was previously a partner at Third Rock Ventures, and before that was a senior vice president at GeneLogic.
Solstice also said that it has appointed John Borgeson as its CFO. He acted as a financial advisor to Solstice from its inception earlier this year, and previously held a variety of roles at Pfizer.